A pilot study of cetuximab and the hedgehog inhibitor IPI-926 in recurrent/metastatic head and neck squamous cell carcinoma

Title
A pilot study of cetuximab and the hedgehog inhibitor IPI-926 in recurrent/metastatic head and neck squamous cell carcinoma
Authors
Keywords
Hedgehog signaling pathway, Phase 1, Cetuximab, Combination therapy, Head and neck squamous cell carcinoma
Journal
ORAL ONCOLOGY
Volume 53, Issue -, Pages 74-79
Publisher
Elsevier BV
Online
2015-12-16
DOI
10.1016/j.oraloncology.2015.11.014

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started